Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association?

BMC Family Practice
Hayatul Najaa MiptahZahirah Tharek

Abstract

Non-alcoholic fatty liver disease (NAFLD) is an emerging novel cardiovascular disease (CVD) risk factor. It's prevalence is increasing globally. However, there is paucity in the evidence showing the association between NAFLD and CVD risk in primary care setting. Therefore, the objectives of this study were to determine the prevalence and factors associated with NAFLD among patients with ≥1 risk factor for NAFLD or CVD attending primary care clinics. A cross sectional study was conducted in two clinics at a university primary care centre. Patients aged ≥18 years with ≥1 risk factor for NAFLD or CVD were recruited. Participants with history of established liver disease or chronic alcohol use were excluded. Socio-demographics, clinical related data, anthropometric measurements and blood investigation results were recorded in a proforma. Diagnosis of NAFLD was made using abdominal ultrasound. The 10-year CVD risk was calculated using the general Framingham Risk Score (FRS). Multiple logistic regression (MLogR) was performed to identify independent factors associated with NAFLD. A total of 263 participants were recruited. The mean age was 52.3 ± 14.7 years old. Male and female were equally distributed. Majority of the participants w...Continue Reading

References

Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jeffrey D BrowningHelen H Hobbs
May 17, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giorgio BedogniStefano Bellentani
Jul 12, 2005·Journal of Hepatology·Jian-Gao FanShi-Yao Chen
Nov 15, 2006·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Okka W HamerClaude B Sirlin
Apr 4, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Nathalie C LeiteClaudia R L Cardoso
May 30, 2009·Journal of Gastroenterology and Hepatology·Anuradha S DassanayakeH Janaka de Silva
Jun 6, 2009·The American Journal of Gastroenterology·Su-Yeon ChoiByung-Hee Oh
Sep 5, 2009·European Journal of Gastroenterology & Hepatology·Llorenç CaballeríaMiren Maite Aizpurua
Dec 31, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Elisa FabbriniSamuel Klein
Feb 4, 2012·Liver International : Official Journal of the International Association for the Study of the Liver·Sombat TreeprasertsukPaul Angulo
Jun 13, 2014·Journal of Clinical Gastroenterology·Douglas R LaBrecqueUNKNOWN World Gastroenterology Organisation
Feb 24, 2016·Journal of Clinical and Experimental Hepatology·Shivaram P SinghPalok Aich
Feb 26, 2016·Indian Journal of Public Health·Anindo MajumdarChandrakant S Pandav
May 24, 2016·Journal of Hepatology·Giovanni TargherCorrado Barbui
Sep 7, 2016·Clinics and Research in Hepatology and Gastroenterology·Nima MotamedFarhad Zamani
Jul 18, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Naga ChalasaniArun J Sanyal
Nov 15, 2017·Primary Care·Patrick H SweetSteven Nguyen
Aug 7, 2018·World Journal of Hepatology·Stelina AlkagietKonstantinos Tziomalos
Aug 28, 2018·Clinical Liver Disease·Erin ClevelandLisa B VanWagner

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

OpenEpi Tool
Statistical Package for Social Sciences ( SPSS )
FRS

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.